Global hunt for kidney cancer treatment clues
NCT ID NCT05287464
Summary
This international study looks back at medical records to understand how different immunotherapy combinations work for people with advanced kidney cancer that has spread. Researchers will analyze data from 1,220 patients who received specific drug combinations as their first treatment. The goal is to identify which patients benefit most from these treatments and learn about factors that affect survival and treatment response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC RENAL CELL CARCINOMA (MRCC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ospedale di Macerata, UOC Oncologia
RECRUITINGMacerata, Macerata, 62100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.